Clinical Trial Update: RALOX or CAPOX + Bevacizumab in the First-line Treatment of Advanced CRC(ROCB Study) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for first-line treatment of advanced colorectal cancer using RALOX or CAPOX plus Bevacizumab (ROCB study).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CAPOX (capecitabine + oxaliplatin)
• RALOX

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN